262 related articles for article (PubMed ID: 22000579)
21. Dimethyl Sulfoxide Prevents Radiation-Induced Oral Mucositis Through Facilitating DNA Double-Strand Break Repair in Epithelial Stem Cells.
Yang C; Tang H; Wang L; Peng R; Bai F; Shan Y; Yu Z; Zhou P; Cong Y
Int J Radiat Oncol Biol Phys; 2018 Dec; 102(5):1577-1589. PubMed ID: 30092334
[TBL] [Abstract][Full Text] [Related]
22. Phase III randomized trial of amifostine as a radioprotector in head and neck cancer.
Brizel DM; Wasserman TH; Henke M; Strnad V; Rudat V; Monnier A; Eschwege F; Zhang J; Russell L; Oster W; Sauer R
J Clin Oncol; 2000 Oct; 18(19):3339-45. PubMed ID: 11013273
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers.
Gujral MS; Patnaik PM; Kaul R; Parikh HK; Conradt C; Tamhankar CP; Daftary GV
Cancer Chemother Pharmacol; 2001 Jul; 47 Suppl():S23-8. PubMed ID: 11561868
[TBL] [Abstract][Full Text] [Related]
24. Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial.
Veness MJ; Foroudi F; Gebski V; Timms I; Sathiyaseelan Y; Cakir B; Tiver KW
Australas Radiol; 2006 Oct; 50(5):468-74. PubMed ID: 16981945
[TBL] [Abstract][Full Text] [Related]
25. Zinc sulfate in the prevention of radiation-induced oropharyngeal mucositis: a prospective, placebo-controlled, randomized study.
Ertekin MV; Koç M; Karslioglu I; Sezen O
Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):167-74. PubMed ID: 14697435
[TBL] [Abstract][Full Text] [Related]
26. A randomized study of very accelerated radiotherapy with and without amifostine in head and neck squamous cell carcinoma.
Bourhis J; De Crevoisier R; Abdulkarim B; Deutsch E; Lusinchi A; Luboinski B; Wibault P; Eschwege F
Int J Radiat Oncol Biol Phys; 2000 Mar; 46(5):1105-8. PubMed ID: 10725619
[TBL] [Abstract][Full Text] [Related]
27. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
[TBL] [Abstract][Full Text] [Related]
28. Effects of systemic or topical administration of sodium selenite on early radiation effects in mouse oral mucosa.
Gehrisch A; Dörr W
Strahlenther Onkol; 2007 Jan; 183(1):36-42. PubMed ID: 17225944
[TBL] [Abstract][Full Text] [Related]
29. Amelioration of radiation-induced oral cavity mucositis and distant bone marrow suppression in fanconi anemia Fancd2-/- (FVB/N) mice by intraoral GS-nitroxide JP4-039.
Berhane H; Shinde A; Kalash R; Xu K; Epperly MW; Goff J; Franicola D; Zhang X; Dixon T; Shields D; Wang H; Wipf P; Li S; Gao X; Greenberger JS
Radiat Res; 2014 Jul; 182(1):35-49. PubMed ID: 24932534
[TBL] [Abstract][Full Text] [Related]
30. Amelioration of Head and Neck Radiation-Induced Mucositis and Distant Marrow Suppression in Fanca
Willis J; Epperly MW; Fisher R; Zhang X; Shields D; Hou W; Wang H; Li S; Wipf P; Parmar K; Guinan E; Steinman J; Greenberger JS
Radiat Res; 2018 Jun; 189(6):560-578. PubMed ID: 29584588
[TBL] [Abstract][Full Text] [Related]
31. Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial.
Bentzen SM; Saunders MI; Dische S; Bond SJ
Radiother Oncol; 2001 Aug; 60(2):123-35. PubMed ID: 11439207
[TBL] [Abstract][Full Text] [Related]
32. Pharmacological protection from radiation ± cisplatin-induced oral mucositis.
Cotrim AP; Yoshikawa M; Sunshine AN; Zheng C; Sowers AL; Thetford AD; Cook JA; Mitchell JB; Baum BJ
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1284-90. PubMed ID: 22197226
[TBL] [Abstract][Full Text] [Related]
33. Comparison between normal tissue reactions and local tumor control in head and neck cancer patients treated by definitive radiotherapy.
Geara FB; Peters LJ; Ang KK; Garden AS; Tucker SL; Levy LB; Brown BW
Int J Radiat Oncol Biol Phys; 1996 Jun; 35(3):455-62. PubMed ID: 8655367
[TBL] [Abstract][Full Text] [Related]
34. Amifostine (ETHYOL) protects rats from mucositis resulting from fractionated or hyperfractionated radiation exposure.
Cassatt DR; Fazenbaker CA; Bachy CM; Kifle G; McCarthy MP
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):901-7. PubMed ID: 15708273
[TBL] [Abstract][Full Text] [Related]
35. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
[TBL] [Abstract][Full Text] [Related]
36. Smart (simultaneous modulated accelerated radiation therapy) boost: a new accelerated fractionation schedule for the treatment of head and neck cancer with intensity modulated radiotherapy.
Butler EB; Teh BS; Grant WH; Uhl BM; Kuppersmith RB; Chiu JK; Donovan DT; Woo SY
Int J Radiat Oncol Biol Phys; 1999 Aug; 45(1):21-32. PubMed ID: 10477002
[TBL] [Abstract][Full Text] [Related]
37. [Z-100 as radiation mucositis protector in head and neck tumor management].
Miyashita T; Morita S; Shibuya H; Takeda M; Horiuchi J
Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Mar; 54(4):295-7. PubMed ID: 8177707
[TBL] [Abstract][Full Text] [Related]
38. TLR9 agonist protects mice from radiation-induced gastrointestinal syndrome.
Saha S; Bhanja P; Liu L; Alfieri AA; Yu D; Kandimalla ER; Agrawal S; Guha C
PLoS One; 2012; 7(1):e29357. PubMed ID: 22238604
[TBL] [Abstract][Full Text] [Related]
39. Flagellin or lipopolysaccharide treatment modified macrophage populations after colorectal radiation of rats.
Lacavé-Lapalun JV; Benderitter M; Linard C
J Pharmacol Exp Ther; 2013 Jul; 346(1):75-85. PubMed ID: 23596059
[TBL] [Abstract][Full Text] [Related]
40. A TLR5 agonist inhibits acute renal ischemic failure.
Fukuzawa N; Petro M; Baldwin WM; Gudkov AV; Fairchild RL
J Immunol; 2011 Oct; 187(7):3831-9. PubMed ID: 21890657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
